Open AccessExhaled Carbon Monoxide and Risk of Metabolic Syndrome and Cardiovascular Disease in the Community
Author(s) -
Susan Cheng,
Asya Lyass,
Joseph M. Massaro,
George O'connor,
John F. Keaney,
Ramachandran S. Vasan
Publication year - 2010
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.110.941013
Subject(s) - medicine , metabolic syndrome , hazard ratio , odds ratio , confidence interval , quartile , cardiology , obesity
Endogenous carbon monoxide (CO) at physiological concentrations is cytoprotective, whereas excess levels reflect underlying oxidative stress, inflammation, and vascular pathology and portend adverse clinical sequelae. However, the relation of exhaled CO to metabolic/vascular risk in the community is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom